MeSH tree: D27.505.519.389.735
A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications ...
Mar 11, 2026
0
17
Sildenafil—an active ingredient also marketed under the name of Viagra—improves symptoms in patients with Leigh syndrome. This has now been reported in the journal Cell by researchers at Charité—Universitätsmedizin Berlin, ...
Mar 11, 2026
0
30
Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most commonly—but not always—a symptom of coronary artery disease (CAD). The term derives from Latin and ...
Jan 13, 2026
0
10
It is known that vasculopathy plays a pivotal role in the pathogenesis of systemic sclerosis (SSc). Vasoactive vasodilating drugs (VVD) are an option. The most recent treatment recommendations from EULAR—The European Alliance ...
Jun 13, 2025
0
21
A recent study reported that sildenafil, sold under the brand name Viagra, and other medicines from the same group called phosphodiesterase type-5 inhibitors may reduce the risk of Alzheimer's disease. But other research ...
Feb 21, 2024
0
30
The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer's disease, according to a study published in Neurology. The study does not prove that erectile dysfunction drugs reduce ...
Feb 7, 2024
0
50
Phosphodiesterase type 5 inhibitors (PDE5i)—an erectile dysfunction drug sold under the names Viagra, Levitra, Cialis, and others—are a common medical treatment for erectile dysfunction (ED) in men with cardiovascular disease ...
Jan 15, 2024
0
109
A small group of patients with type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, a medication used to treat erectile dysfunction. The result from the University ...
May 4, 2023
0
130
A comprehensive research study manuscript examining the impact of erectile dysfunction drugs on major adverse cardiovascular events (MACE) and mortality has been published in The Journal of Sexual Medicine by scientists from ...
Jan 31, 2023
0
460
Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct. 4 in Brain Communications.
Oct 19, 2022
0
59
